ENG/中
美国
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
百济神州
220.54
-17.9700
-7.53%
盘后:
215.00
-5.5400
-2.51%
16:28 EDT
成交量:
70.02万
成交额:
1.55亿
市值:
237.16亿
市盈率:
-36.01
高:
235.03
开:
220.15
低:
214.12
收:
238.51
数据加载中...
总览
公司
新闻
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻
BeiGene(ONC.US)获加拿大皇家银行首次覆盖,给予优于大市评级, 目标价312.00美元。
金融界
·
昨天
百济神州:将于2025年5月21日召开2025年年度股东大会
公司公告
·
昨天
百济神州4月4日成交额为1.63亿美元
市场透视
·
04-05
百济神州终止TIGIT抗体欧司珀利单抗肺癌治疗临床开发计划 已累计投入超20亿元
每日经济新闻
·
04-04
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ONC"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":220.54,"timestamp":1744056000000,"preClose":238.51,"halted":0,"volume":700187,"hourTrading":{"tag":"盘后","latestPrice":215,"preClose":220.54,"latestTime":"16:28 EDT","volume":1280,"amount":282237.2608,"timestamp":1744057721804},"delay":0,"floatShares":74326060,"shares":107535059,"eps":-6.124009,"marketStatus":"盘后交易","change":-17.97,"latestTime":"04-07 16:35:20 EDT","open":220.15,"high":235.03,"low":214.1224,"amount":154789449.916088,"amplitude":0.087659,"askPrice":222.6,"askSize":373,"bidPrice":217,"bidSize":2,"shortable":0,"etf":0,"ttmEps":-6.124009,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1744070400000},"marketStatusCode":4,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":238.51,"preHourTrading":{"tag":"盘前","latestPrice":220,"preClose":238.51,"latestTime":"09:29 EDT","volume":3027,"amount":709096.99845,"timestamp":1744032599909},"postHourTrading":{"tag":"盘后","latestPrice":215,"preClose":220.54,"latestTime":"16:28 EDT","volume":1280,"amount":282237.2608,"timestamp":1744057721804},"volumeRatio":1.079562,"impliedVol":0.6809,"impliedVolPercentile":0.9846},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":74326060,"roa":"-6.07%","roe":"-18.77%","lyrEps":-6.124009,"volumeRatio":1.079562,"shares":107535059,"dividePrice":0,"high":235.03,"amplitude":0.087659,"preClose":238.51,"low":214.1224,"week52Low":126.9681,"pbRate":"7.12","psRate":"6.22","week52High":287.88,"institutionHeld":0,"latestPrice":220.54,"committee":-0.989333,"eps":-6.124009,"divideRate":0,"volume":700187,"delay":0,"ttmEps":-6.124009,"open":220.15,"prevYearClose":184.71,"prevWeekClose":238.51,"prevMonthClose":272.17,"prevQuarterClose":272.17,"fiveDayClose":272.17,"twentyDayClose":242.66,"sixtyDayClose":177.88},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ONC\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525402802","title":"BeiGene(ONC.US)获加拿大皇家银行首次覆盖,给予优于大市评级, 目标价312.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2525402802","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525402802?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 23:03","pubTimestamp":1744038193,"startTime":"0","endTime":"0","summary":"BeiGene(ONC.US)获加拿大皇家银行首次覆盖,给予优于大市评级, 目标价312.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/07230349360634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ONC","06160"],"gpt_icon":0},{"id":"2525401265","title":"百济神州:将于2025年5月21日召开2025年年度股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2525401265","media":"公司公告","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525401265?lang=zh_cn&edition=fundamental","pubTime":"2025-04-07 19:40","pubTimestamp":1744026059,"startTime":"0","endTime":"0","summary":"百济神州公告,公司将于2025年5月21日召开年度股东大会,会议将采用现场投票、邮寄投票(仅限非A股股东)和网络投票相结合的方式。会议地点位于开曼群岛,网络投票通过上海证券交易所股东大会网络投票系统进行。会议将审议包括重选董事、批准独立审计师及授权董事会发行股份等12项议案。涉及融资融券、转融通业务的相关账户需按照监管指引执行投票程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407195046a450e254&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250407195046a450e254&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","06160","BK4139","ONC"],"gpt_icon":0},{"id":"2525676393","title":"百济神州4月4日成交额为1.63亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525676393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525676393?lang=zh_cn&edition=fundamental","pubTime":"2025-04-05 10:07","pubTimestamp":1743818876,"startTime":"0","endTime":"0","summary":"美东时间2025年4月4日,百济神州成交额为1.63亿美元,成交额较昨日增加57.72%,当日成交量为67.53万股。百济神州于2025年4月4日跌9.76%,报238.51美元,该股过去5个交易日跌10.8%,年初至今涨29.13%,过去60日涨36.21%。百济神州有自己的团队进行全球临床试验。截至2023年,百济神州的核心药物是百悦泽,这是一种治疗各种血癌的小分子药物,占百济神州收入的50%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405100805a44e6ac7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405100805a44e6ac7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONC"],"gpt_icon":0},{"id":"2524229551","title":"百济神州终止TIGIT抗体欧司珀利单抗肺癌治疗临床开发计划 已累计投入超20亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524229551","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524229551?lang=zh_cn&edition=fundamental","pubTime":"2025-04-04 11:53","pubTimestamp":1743738808,"startTime":"0","endTime":"0","summary":"每经记者 林姿辰 每经编辑 文多4月3日,百济神州宣布停止TIGIT抗体Ociperlimab作为肺癌潜在治疗方法的临床开发计划。截至2024年12月,欧司珀利单抗开发项目已入组2000多例患者。截至2024年上半年末,百济神州已在欧司珀利单抗项目累计投入20.90亿元。据报道,因针对肺癌的数项Ⅲ期临床试验未达到预期效果,罗氏制药公司在2024年年报中宣布终止部分TIGIT抗体相关临床试验,仅保留肝癌适应症的临床研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040411541094cbb900&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040411541094cbb900&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","06160","ONC","688235"],"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"date":"2025-05-14","symbol":"ONC","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.74,"defaultRemindTime":1747209600000,"name":null,"time":"","dateTimestamp":1747195200000,"actualEps":null},{"market":"US","date":"2025-02-27","symbol":"ONC","fiscalQuarterEnding":"2024/12","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2024-11-12","symbol":"ONC","fiscalQuarterEnding":"2024/09","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-08-07","symbol":"ONC","fiscalQuarterEnding":"2024/06","expectedEps":-2.1,"name":null,"time":"盘前","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-05-11","symbol":"ONC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715400000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.6667,"hold":0.0476,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":21,"updateTime":1740974400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2025-04-04","current":-44.082326,"percent":0.112903,"low":-46.072488,"twenty":-43.290212,"median":-30.877376,"eighty":-28.597906,"high":-22.805663,"avg":-34.459915,"sd":7.707641,"marketCap":28423666794},"quantilePoints":[{"date":"2025-01-03","current":-23.85925,"twenty":-23.85925,"median":-23.85925,"eighty":-23.85925,"marketCap":19590153584},{"date":"2025-01-10","current":-23.169003,"twenty":-23.588216,"median":-23.51181,"eighty":-23.096335,"marketCap":18938568040},{"date":"2025-01-17","current":-26.770744,"twenty":-26.217794,"median":-23.689854,"eighty":-23.142836,"marketCap":21882666138},{"date":"2025-01-24","current":-28.798988,"twenty":-27.60701,"median":-25.13119,"eighty":-23.374687,"marketCap":23683664763},{"date":"2025-01-31","current":-29.253094,"twenty":-28.895055,"median":-26.770744,"eighty":-23.516999,"marketCap":24179205805},{"date":"2025-02-07","current":-29.699946,"twenty":-29.114029,"median":-28.456686,"eighty":-23.723733,"marketCap":24422582437},{"date":"2025-02-14","current":-29.279798,"twenty":-29.132261,"median":-28.781271,"eighty":-23.9826,"marketCap":24061904635},{"date":"2025-02-21","current":-31.546239,"twenty":-29.269116,"median":-28.798062,"eighty":-24.917918,"marketCap":26058437677},{"date":"2025-02-28","current":-46.072488,"twenty":-30.312806,"median":-28.916244,"eighty":-26.238043,"marketCap":29706894943},{"date":"2025-03-07","current":-42.702936,"twenty":-33.205878,"median":-29.060335,"eighty":-26.487572,"marketCap":27534255325},{"date":"2025-03-14","current":-42.304107,"twenty":-40.627279,"median":-29.228112,"eighty":-26.926934,"marketCap":27277096074},{"date":"2025-03-21","current":-43.63686,"twenty":-41.989697,"median":-29.279798,"eighty":-27.60701,"marketCap":28136436571},{"date":"2025-03-28","current":-43.795471,"twenty":-42.273573,"median":-29.808923,"eighty":-28.393975,"marketCap":28238706493},{"date":"2025-04-04","current":-44.082326,"twenty":-43.290212,"median":-30.877376,"eighty":-28.597906,"marketCap":28423666794}],"updateTime":1744051638888}}}